CRM

Salesforce
D

CRM

Arincen83/100B

Salesforce executives and insider trading

Parker Harris sold 134,662 shares for 31.61M USD in 5 sales over the last twelve months, the last on 2 December 2025, and bought none on the open market.

Over the last twelve months Salesforce's insiders sold 143,055 shares for 33.71M USD in 8 sales on the open market, and bought 107,253 shares in 6 purchases.

Insiders over the last twelve months

Insider sales
8
Shares sold
143,055
Value sold
33.71M USD
Insider purchases
6

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
999.45K USD
3 months
1.17M USD
999.45K USD
6 months
1.17M USD
27.52M USD
1 year
33.71M USD
28.38M USD
2 years
80.47M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Parker Harris CEOCo-Founder, Advisor to the CEO & Director59134,66231.61M USD—2 Dec 2025166,353
G Mason Morfit Director, other: See Remarks———96,000—2,994,509
David Blair Kirk Director———8,682—18,748
Craig Conway Director—4,5001.17M USD—4 Sept 20268,519
Neelie Kroes Director—3,893929.28K USD—14 Jan 20268,557
Laura Alber Director———2,571—10,413

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
18 Sept 2026David Blair KirkPurchase4,176239.33999.45K USD18,748Form 4
4 Sept 2026Craig ConwaySale1,418260.50369.38K USD8,519Form 4
4 Sept 2026Craig ConwaySale3,082260.66803.36K USD5,437Form 4
19 Mar 2026Laura AlberPurchase2,080194.59404.75K USD9,530Form 4
19 Mar 2026Laura AlberPurchase491194.5495.52K USD7,450Form 4
18 Mar 2026David Blair KirkPurchase2,570194.62500.18K USD13,689Form 4
14 Jan 2026Neelie KroesSale3,893238.70929.28K USD7,299Form 4
17 Dec 2025David Blair KirkPurchase1,936258.64500.72K USD10,677Form 4
5 Dec 2025G Mason MorfitPurchase96,000260.5825.02M USD2,994,509Form 4
2 Dec 2025Parker HarrisSale13,225232.523.08M USD261,204Form 4
2 Dec 2025Parker HarrisSale15,873233.253.70M USD245,331Form 4
2 Dec 2025Parker HarrisSale39,442234.619.25M USD205,889Form 4
2 Dec 2025Parker HarrisSale57,475235.4413.53M USD148,414Form 4
2 Dec 2025Parker HarrisSale8,647236.172.04M USD139,767Form 4
3 Nov 2025Marc R. BenioffSale17255.764.35K USD11,911,676Form 4

Common questions about Salesforce's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.